查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829387

2025年全球子宫肌瘤栓塞装置市场报告

Uterine Fibroid Embolization Device Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，子宫肌瘤栓塞器械市场规模稳定成长，从2024年的56.2亿美元增加到2025年的58.9亿美元，复合年增长率为4.7%。这段历史时期的成长可归因于子宫肌瘤发病率的上升、对非手术治疗方案的偏好、认知和教育倡议、对女性健康的关注、向门诊手术的转变以及医生培训计画的开展。

子宫肌瘤栓塞器械市场规模预计将在未来几年稳步成长，到2029年将达到69.6亿美元，复合年增长率为4.3%。预测期内的成长可归因于人们对非侵入性治疗的认识不断提高、医疗服务的全球扩张、对女性医疗保健的日益关注、与多学科护理的整合以及门诊服务的扩展。预测期内的主要趋势包括微创治疗的普及、栓塞剂的进步、个人化治疗方法、对门诊UFE治疗的关注、影像技术的整合以及对生物可吸收栓塞剂的研究。

子宫肌瘤栓塞装置是医疗设备。子宫肌瘤是子宫内形成的良性肿瘤，装置可以限制肌瘤的血液供应，使其缩小并最终消失。

子宫肌瘤栓塞的主要技术包括手术、腹腔镜手术、切除和栓塞技术。手术技术是指医护人员采用的特定方法和程序。这些设备可用于多种治疗模式，包括侵入性、微创性和非侵入性治疗。此外，它们也应用于各种医疗机构，包括医院、诊所和门诊手术中心。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供子宫肌瘤栓塞治疗设备的市场统计数据，包括全球市场规模、各地区市场份额、竞争对手的子宫肌瘤栓塞治疗设备市场份额、详细的子宫肌瘤栓塞治疗设备细分市场、市场趋势和商机，以及您在子宫肌瘤栓塞治疗设备行业取得成功所需的数据。本子宫肌瘤栓塞治疗设备市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年4.3%的预测成长率，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。这项影响将直接影响美国，导致来自比利时和英国等主要地区的校准栓塞颗粒和微导管输送系统的供应链中断，可能导致子宫肌瘤患者的治疗延误。此外，由于贸易紧张局势加剧和限制措施加剧，互惠关税以及对全球经济和贸易的负面影响将对全球经济和贸易产生更广泛的负面影响。

微创手术需求的不断增长预计将推动子宫肌瘤栓塞器械市场的成长。微创手术利用小切口或自然体孔进入并治疗内臟器官、组织和结构，同时最大限度地减少对患者身体的创伤。子宫肌瘤栓塞器械在这些手术中发挥关键作用，它能够透过微创手术有效治疗子宫肌瘤。这些专用器械设计用于小切口，减少对周围组织的影响，满足了人们对微创医疗日益增长的偏好，最终改善了患者的治疗效果。例如，2023年8月，美国整形外科和美容医学协会－美学协会(Aesthetic Society)报告称，美国在整容手术上的支出超过118亿美元，年增2%。因此，微创手术需求的不断增长正在推动子宫肌瘤栓塞器械市场的扩张。

人口老化也有望推动子宫肌瘤栓塞术市场的扩张。在65岁及以上人口的老化社会中，子宫肌瘤栓塞术作为一种微创手术治疗方法正日益受到关注。这类患者可以透过这些设备缓解过度出血和骨盆腔疼痛等症状。根据世界卫生组织（WHO）2022年10月的报告，预计全球60岁以上人口将在2022年达到14亿，到2050年将翻一番，达到21亿。因此，人口老化是子宫肌瘤栓塞术市场发展的驱动力。

子宫肌瘤栓塞器械市场由提供微创手术、非侵入性手术、微创手术、射频消融术、药物治疗、荷尔蒙疗法和栓塞手术等服务的营业单位所获得的收益组成。市场价值包括服务提供者销售的或包含在其服务产品中的相关产品的价值。子宫肌瘤栓塞器械市场还包括药物、子子宫镜器械、腹腔镜器械、射频消融器械、子宫内膜消融器械、子宫切除器械和机器人手术系统的销售。该市场的价值是“出厂价”，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场中的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球子宫肌瘤栓塞设备：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球子宫肌瘤栓塞设备市场：成长率分析
  • 全球子宫肌瘤栓塞设备市场表现：规模与成长，2019-2024
  • 全球子宫肌瘤栓塞设备市场预测：规模与成长，2024-2029年，2034年
  • 全球子宫肌瘤栓塞设备：总目标市场（TAM）

第六章 市场细分

  • 全球子宫肌瘤栓塞设备市场：依技术、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 手术技术
  • 腹腔镜手术
  • 消融技术
  • 栓塞治疗
  • 全球子宫肌瘤栓塞设备市场（依治疗方法、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 侵入性治疗
  • 微创治疗
  • 非侵入性治疗
  • 全球子宫肌瘤栓塞设备市场：依最终用户、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 门诊手术中心
  • 全球子宫肌瘤栓塞设备市场：依手术类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 开放性手术
  • 子宫肌瘤切除术
  • 全球子宫肌瘤栓塞设备市场：依腹腔镜手术类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 腹腔镜子宫肌瘤切除术
  • 腹腔镜子宫切除术
  • 全球子宫肌瘤栓塞设备市场：依消融技术（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 射频消融
  • 微波消融
  • 冷冻疗法
  • 全球子宫肌瘤栓塞设备市场：依栓塞类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 经导管动脉栓塞术（TAE）
  • 子宫动脉栓塞术（UAE）

第七章 区域和国家分析

  • 全球子宫肌瘤栓塞设备市场：区域分析、预测与趋势（2019-2024 年、2024-2029 年及 2034 年）
  • 全球子宫肌瘤栓塞设备市场：依国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 子宫肌瘤栓塞装置市场：竞争格局
  • 子宫肌瘤栓塞设备市场：公司简介
    • Johnson and Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Stryker Corporation
  • Boston Scientific Corporation
  • GE HealthCare Technologies Inc.
  • Olympus Corporation
  • Terumo Corporation
  • Smith and Nephew plc.
  • Ethicon Inc.
  • Hologic Inc.
  • CooperSurgical Inc.
  • Ferring BV
  • Cook Medical Inc.
  • Karl Storz GmbH
  • Merit Medical Systems
  • CONMED Corporation
  • Amsino International Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 子宫肌瘤栓塞设备市场 2029：提供新机会的国家
  • 子宫肌瘤栓塞设备市场 2029：细分市场带来新机会
  • 子宫肌瘤栓塞设备市场 2029 年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r29208u

A uterine fibroid embolization device is a medical device used in the treatment of noncancerous tumors, specifically uterine fibroids, through a minimally invasive procedure. Uterine fibroids are benign growths in the uterus, and this device functions by restricting the blood supply to these fibroids, causing them to shrink and ultimately disappear.

The main types of technologies associated with uterine fibroid embolization devices include surgical techniques, laparoscopic techniques, ablation techniques, and embolization techniques. Surgical techniques involve specific methods and procedures employed by medical professionals. These devices are utilized in various treatment modes, including invasive, minimally invasive, and non-invasive treatments. Additionally, they find application in diverse healthcare settings such as hospitals, clinics, and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The uterine fibroid embolization device market research report is one of a series of new reports from The Business Research Company that provides uterine fibroid embolization device market statistics, including uterine fibroid embolization device industry global market size, regional shares, competitors with a uterine fibroid embolization device market share, detailed uterine fibroid embolization device market segments, market trends and opportunities, and any further data you may need to thrive in the uterine fibroid embolization device industry. This uterine fibroid embolization device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The uterine fibroid embolization device market size has grown steadily in recent years. It will grow from $5.62 billion in 2024 to $5.89 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to increasing incidence of uterine fibroids, preference for non-surgical alternatives, awareness and education initiatives, focus on women's health, shift towards outpatient procedures, physician training programs.

The uterine fibroid embolization device market size is expected to see steady growth in the next few years. It will grow to $6.96 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing awareness of non-invasive treatments, global expansion of healthcare services, rise in female healthcare initiatives, integration with multidisciplinary care, expansion of outpatient services. Major trends in the forecast period include increasing adoption of minimally invasive procedures, advancements in embolic agents, personalized treatment approaches, focus on outpatient ufe procedures, integration of imaging technologies, research on bioresorbable embolic agents.

The forecast of 4.3% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for calibrated embolic particles and microcatheter delivery systems, sourced from key regions such as Belgium and the United Kingdom, could lead to treatment delays for fibroid patients.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for minimally invasive surgeries is expected to drive the growth of the uterine fibroid embolization device market. Minimally invasive surgeries involve using small incisions or natural body openings to access and treat internal organs, tissues, or structures, minimizing trauma to the patient's body. Uterine fibroid embolization devices play a crucial role in these procedures by effectively treating uterine fibroids while keeping invasiveness to a minimum. These specialized devices are designed to use small incisions, reducing the impact on surrounding tissues, and catering to the rising preference for less invasive medical treatments, ultimately improving patient outcomes. For example, in August 2023, The Aesthetic Society, a US-based organization in plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures, marking a 2% increase from the previous year. Thus, the growing demand for minimally invasive surgeries is driving the expansion of the uterine fibroid embolization device market.

The growing aging population is also expected to contribute to the expansion of the uterine fibroid embolization devices market. The aging population, representing individuals aged 65 years and older, benefits from uterine fibroid embolization devices as a minimally invasive alternative to surgery for addressing symptomatic fibroids. This demographic experiences relief from symptoms such as excessive bleeding and pelvic pain through these devices. According to the World Health Organization's October 2022 report, the global population aged 60 years and older reached 1.4 billion in 2022, and by 2050, it is projected to double to 2.1 billion. Therefore, the increasing aging population acts as a driver for the uterine fibroid embolization devices market.

Major companies in the uterine fibroid embolization device market are focusing on developing innovative products such as the TruClear system to address the growing demand for minimally invasive treatments for uterine fibroids, aiming to enhance safety and efficacy. The TruClear system, launched by Medtronic Private Limited in November 2022, is a mechanical hysteroscopic tissue removal system used for treating intrauterine abnormalities. It features a flexible catheter inserted through the cervix into the uterus, incorporating a spinning nitinol wire loop, continuous inflow and outflow, integrated suction, and high-definition imaging, contributing to the precision and safety of uterine fibroid treatment.

In October 2024, Hologic Inc., a US-based medical technology company, acquired Gynesonics for $350 million. Through this acquisition, Hologic seeks to expand its range of minimally invasive treatment options for women's health, with a focus on managing uterine fibroids and heavy menstrual bleeding. Gynesonics Inc. is a US-based medical technology company specializing in the development of minimally invasive solutions for treating symptomatic uterine fibroids.

Major companies operating in the uterine fibroid embolization device market report are Johnson and Johnson Pvt Ltd., Abbott Laboratories, Medtronic plc., Siemens Healthineers Ltd., Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, GE HealthCare Technologies Inc., Olympus Corporation, Terumo Corporation, Smith and Nephew plc., Ethicon Inc., Hologic Inc., CooperSurgical Inc., Ferring B.V., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Amsino International Inc., Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd., INSIGHTEC Ltd., Hironic Co.Ltd., Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC, Hitachi Medical Corporation

North America was the largest region in the uterine fibroid embolization device market in 2024. The regions covered in the uterine fibroid embolization device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the uterine fibroid embolization device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The uterine fibroid embolization device market consists of revenues earned by entities by provide services such as minimally invasive procedures, non-invasive procedures, minimally invasive procedures, radiofrequency ablation, medication and hormonal therapy, and embolization procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The uterine fibroid embolization device market also includes sales of medications, hysteroscopic devices, laparoscopic devices, radiofrequency ablation devices, endometrial ablation devices, hysterectomy devices, and robotic surgical systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Uterine Fibroid Embolization Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on uterine fibroid embolization device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for uterine fibroid embolization device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The uterine fibroid embolization device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Surgical Techniques; Laparoscopic Techniques; Ablation Techniques; Embolization Techniques
  • 2) By Mode Of Treatment: Invasive Treatment; Minimally Invasive Treatment; Non-Invasive Treatment
  • 3) By End User: Hospitals; Clinics; Ambulatory Surgical Center
  • Subsegments:
  • 1) By Surgical Techniques: Open Surgery; Myomectomy
  • 2) By Laparoscopic Techniques: Laparoscopic Myomectomy; Laparoscopic Hysterectomy
  • 3) By Ablation Techniques: Radiofrequency Ablation; Microwave Ablation; Cryoablation
  • 4) By Embolization Techniques: Transcatheter Arterial Embolization (TAE); Uterine Artery Embolization (UAE)
  • Companies Mentioned: Johnson and Johnson Pvt Ltd.; Abbott Laboratories; Medtronic plc.; Siemens Healthineers Ltd.; Koninklijke Philips N.V.; Stryker Corporation; Boston Scientific Corporation; GE HealthCare Technologies Inc.; Olympus Corporation; Terumo Corporation; Smith and Nephew plc.; Ethicon Inc.; Hologic Inc.; CooperSurgical Inc.; Ferring B.V.; Cook Medical Inc.; Karl Storz GmbH; Merit Medical Systems; CONMED Corporation; Amsino International Inc.; Lumenis Ltd.; Richard Wolf GmbH; BTG International Ltd.; Healthium MedTech Pvt. Ltd.; INSIGHTEC Ltd.; Hironic Co.Ltd; Minerva Surgical Inc.; Gynesonics Inc.; Advanced Surgical Concepts PLLC; Hitachi Medical Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Uterine Fibroid Embolization Device Market Characteristics

3. Uterine Fibroid Embolization Device Market Trends And Strategies

4. Uterine Fibroid Embolization Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Uterine Fibroid Embolization Device Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Uterine Fibroid Embolization Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Uterine Fibroid Embolization Device Market Growth Rate Analysis
  • 5.4. Global Uterine Fibroid Embolization Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Uterine Fibroid Embolization Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Uterine Fibroid Embolization Device Total Addressable Market (TAM)

6. Uterine Fibroid Embolization Device Market Segmentation

  • 6.1. Global Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical Techniques
  • Laparoscopic Techniques
  • Ablation Techniques
  • Embolization Techniques
  • 6.2. Global Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Invasive Treatment
  • Minimally Invasive Treatment
  • Non-Invasive Treatment
  • 6.3. Global Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Center
  • 6.4. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Surgical Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Open Surgery
  • Myomectomy
  • 6.5. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Laparoscopic Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laparoscopic Myomectomy
  • Laparoscopic Hysterectomy
  • 6.6. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Ablation Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • 6.7. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Embolization Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Arterial Embolization (TAE)
  • Uterine Artery Embolization (UAE)

7. Uterine Fibroid Embolization Device Market Regional And Country Analysis

  • 7.1. Global Uterine Fibroid Embolization Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Uterine Fibroid Embolization Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Uterine Fibroid Embolization Device Market

  • 8.1. Asia-Pacific Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Uterine Fibroid Embolization Device Market

  • 9.1. China Uterine Fibroid Embolization Device Market Overview
  • 9.2. China Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Uterine Fibroid Embolization Device Market

  • 10.1. India Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Uterine Fibroid Embolization Device Market

  • 11.1. Japan Uterine Fibroid Embolization Device Market Overview
  • 11.2. Japan Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Uterine Fibroid Embolization Device Market

  • 12.1. Australia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Uterine Fibroid Embolization Device Market

  • 13.1. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Uterine Fibroid Embolization Device Market

  • 14.1. South Korea Uterine Fibroid Embolization Device Market Overview
  • 14.2. South Korea Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Uterine Fibroid Embolization Device Market

  • 15.1. Western Europe Uterine Fibroid Embolization Device Market Overview
  • 15.2. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Uterine Fibroid Embolization Device Market

  • 16.1. UK Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Uterine Fibroid Embolization Device Market

  • 17.1. Germany Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Uterine Fibroid Embolization Device Market

  • 18.1. France Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Uterine Fibroid Embolization Device Market

  • 19.1. Italy Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Uterine Fibroid Embolization Device Market

  • 20.1. Spain Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Uterine Fibroid Embolization Device Market

  • 21.1. Eastern Europe Uterine Fibroid Embolization Device Market Overview
  • 21.2. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Uterine Fibroid Embolization Device Market

  • 22.1. Russia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Uterine Fibroid Embolization Device Market

  • 23.1. North America Uterine Fibroid Embolization Device Market Overview
  • 23.2. North America Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Uterine Fibroid Embolization Device Market

  • 24.1. USA Uterine Fibroid Embolization Device Market Overview
  • 24.2. USA Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Uterine Fibroid Embolization Device Market

  • 25.1. Canada Uterine Fibroid Embolization Device Market Overview
  • 25.2. Canada Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Uterine Fibroid Embolization Device Market

  • 26.1. South America Uterine Fibroid Embolization Device Market Overview
  • 26.2. South America Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Uterine Fibroid Embolization Device Market

  • 27.1. Brazil Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Uterine Fibroid Embolization Device Market

  • 28.1. Middle East Uterine Fibroid Embolization Device Market Overview
  • 28.2. Middle East Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Uterine Fibroid Embolization Device Market

  • 29.1. Africa Uterine Fibroid Embolization Device Market Overview
  • 29.2. Africa Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Uterine Fibroid Embolization Device Market Competitive Landscape And Company Profiles

  • 30.1. Uterine Fibroid Embolization Device Market Competitive Landscape
  • 30.2. Uterine Fibroid Embolization Device Market Company Profiles
    • 30.2.1. Johnson and Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Uterine Fibroid Embolization Device Market Other Major And Innovative Companies

  • 31.1. Stryker Corporation
  • 31.2. Boston Scientific Corporation
  • 31.3. GE HealthCare Technologies Inc.
  • 31.4. Olympus Corporation
  • 31.5. Terumo Corporation
  • 31.6. Smith and Nephew plc.
  • 31.7. Ethicon Inc.
  • 31.8. Hologic Inc.
  • 31.9. CooperSurgical Inc.
  • 31.10. Ferring B.V.
  • 31.11. Cook Medical Inc.
  • 31.12. Karl Storz GmbH
  • 31.13. Merit Medical Systems
  • 31.14. CONMED Corporation
  • 31.15. Amsino International Inc.

32. Global Uterine Fibroid Embolization Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Uterine Fibroid Embolization Device Market

34. Recent Developments In The Uterine Fibroid Embolization Device Market

35. Uterine Fibroid Embolization Device Market High Potential Countries, Segments and Strategies

  • 35.1 Uterine Fibroid Embolization Device Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Uterine Fibroid Embolization Device Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Uterine Fibroid Embolization Device Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer